EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies

Claudiu Natanael Roznovan, Luminița Gabriela Măruțescu iD, Gratiela Gradisteanu Pircalabioru iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Claudiu Natanael Roznovan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Medical Oncology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immuno-oncology has rapidly evolved into a cornerstone of modern cancer therapy, offering promising avenues for durable responses and personalized treatment strategies. This narrative review provides a thorough overview of the mechanisms underlying tumor–immune system interactions and the therapeutic innovations emerging from this knowledge. Central to this discussion is the tumor microenvironment (TME), a complex ecosystem of immune and stromal cells that supports tumor growth and shapes therapeutic outcomes. Key cellular and molecular factors within the TME are examined, along with diverse immune escape strategies. We further analyze the landscape of immunotherapeutic approaches, including immune checkpoint inhibitors, cancer vaccines, adoptive cell therapies such as CAR-T cells, and cytokine-based interventions. This review also addresses the increasing importance of predictive biomarkers in immuno-oncology, particularly in patient stratification, monitoring resistance, and managing immunotherapy-related toxicity. Finally, we explore the emerging role of the microbiome as a modulator of immunotherapy efficacy, shedding light on host–microbe–immune interactions that may influence clinical outcomes. By integrating current biological insights with therapeutic innovation, this review outlines the challenges and opportunities ahead in immuno-oncology and emphasizes the need for translational research and cross-disciplinary collaboration to optimize cancer immunotherapy in the era of precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyMedical OncologyHumansTumor MicroenvironmentPrecision MedicineCancer VaccinesAnimalsImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

biomarker-guided treatmentimmune checkpoint inhibitorsimmuno-oncologyimmunotherapymicrobiomeprecision oncologytumor microenvironmenttumor–immune interactions

Substanzen

Cancer VaccinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania.
  • Research Institute of University of Bucharest, 050107 Bucharest, Romania.
  • eBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.

ORCID-Profile: Luminița Gabriela Măruțescu, Gratiela Gradisteanu Pircalabioru

Zitieren

APA

Roznovan, C. N., Măruțescu, L. G., & Gradisteanu Pircalabioru, G. (2025). Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136177

Vancouver

Roznovan CN, Măruțescu LG, Gradisteanu Pircalabioru G. Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136177

BibTeX
@article{Roznovan2025,
  author = {Roznovan, Claudiu Natanael and Măruțescu, Luminița Gabriela and Gradisteanu Pircalabioru, Gratiela},
  title = {Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136177}
}
Kostenlos starten →